Schistosomiasis

072-Merck-Schisto-Ethiopia-2018.jpg

These tablets are distributed on a biannual basis as part of large campaigns with the aim of alleviating symptoms and preventing any long-term, irreversible consequences of schistosomiasis infection. The drug is safe, effective, and affordable, but it is not enough on its own. 

092-Virtual Exhibition-Schisto-Ethiopia-2018.jpg

Merck partnered with NALA in 2017 to enable their drug campaigns to have a greater impact. NALA has since worked to mobilize communities in Ethiopia through health education, national policy, and water, sanitation, and hygiene (WASH) solutions.

3 years into the project, there is already a decrease of over 60% in schistosomiasis prevalence among school children. Two years of the project remain with the goal of achieving an 80% reduction in the prevalence of intestinal worms.